In March 2022, plaintiff Kline initiated a lawsuit against Monsanto and Nouryon Chemicals LLC, asserting that his regular use of Roundup resulted in his non-Hodgkin’s lymphoma diagnosis. Kline stated that he had used Roundup for six months per year over several years prior to his diagnosis.
Despite Kline’s claims, the jury swiftly returned a defense verdict after just two hours of deliberation, indicating a clear decision. Nevertheless, the plaintiff intends to appeal the verdict, citing issues such as the exclusion of certain evidence, such as the Environmental Protection Agency’s safety evaluation of Roundup and the International Agency for Research on Cancer’s findings that Roundup is a carcinogen.
This legal development has further shaped the landscape of Roundup-related lawsuits, with the average verdict in Pennsylvania now standing at $607 million. The case highlights the complexities and ongoing controversies surrounding the use of Roundup and the legal battles it has triggered.
